Gallium-desferrioxamine protects the cat retina against injury after ischemia and reperfusion.
This study sought to determine whether gallium-desferrioxamine (Ga/DFO) can curb free radical formation and mitigate biochemical and electrophysiological parameters of injury in the cat retina subjected to ischemia followed by reperfusion. For the biochemical studies, cat eyes were subjected to 90 min of retinal ischemia followed by 5 min of reperfusion, and enucleation of one eye of each cat was used to measure retinal reperfusion injury. Before enucleation of fellow eyes, 2.5 mg/kg Ga/DFO was injected intravenously 5 min before reperfusion. The flux of hydroxyl radicals, as measured directly by conversion of salicylate to 2,3- and 2,5-dihydroxybenzoic acid (2,3- and 2,5-DHBA), was significantly lower in Ga/DFO-treated eyes. The mean normalized level of 2,3-DHBA (considered a specific marker of hydroxyl radicals) was 3.5 times higher in untreated eyes. Ga/DFO caused a significant reduction, by 2.56-fold, in lipid peroxidation, as reflected by levels of malondialdehyde. Ascorbic acid, a natural antioxidant present in the retina, is severely depleted in untreated eyes. In contrast, in Ga/DFO-treated eyes, levels were 10 times higher than the control. Energy charge was 2.38 times higher in treated eyes. Levels of purine catabolites (hypoxanthine, xanthine, and uric acid) that reflect excessive metabolism of purine nucleotides were approximately twice higher in untreated retinas. Electroretionographic studies, performed on a different subset of animals, substantiated the biochemical results. In Ga/DFO-treated eyes the amplitude of the mixed cone-rod response b-wave (as compared with fellow nonischemic eyes) fully recovered within 24 h after ischemia (b-wave ratio 1.04 +/- 0.09, [mean +/- SEM]) whereas ischemic/reperfused and nontreated eyes recovered to only 0.33 +/- 0. 05. The results show that severe biochemical and functional retinal injury occurs in cat eyes subjected to ischemia and reperfusion. These severe changes were significantly reduced by a single administration of Ga/DFO just before reperfusion. We hypothesize that the protection afforded by Ga/DFO is due to a combined effect of "Push-Pull" mechanisms interfering with transition metal-dependent and free radical-mediated injurious processes.
Banin
E
E
Department of Ophthalmology, Hadassah University Hospital, Jerusalem, Israel. banine@md2.huji.ac.il
Berenshtein
E
E
Kitrossky
N
N
Pe'er
J
J
Chevion
M
M
D000227:Adenine Nucleotides / Q000378:metabolism; D000818:Animals; D002415:Cats; D003676:Deferoxamine / Q000031:analogs & derivatives* / Q000494:pharmacology; D004596:Electroretinography; D004734:Energy Metabolism / Q000187:drug effects; D006150:Guanine Nucleotides / Q000378:metabolism; D007429:Intraocular Pressure; D015227:Lipid Peroxidation / Q000187:drug effects; D015282:Octreotide / Q000031:analogs & derivatives* / Q000494:pharmacology; D015424:Reperfusion; D015427:Reperfusion Injury / Q000517:prevention & control*; D012160:Retina / Q000187:drug effects* / Q000502:physiology / Q000503:physiopathology; D012171:Retinal Vessels / Q000187:drug effects / Q000502:physiology* / Q000503:physiopathology; D013997:Time Factors
D000227:Adenine Nucleotides; D006150:Guanine Nucleotides; C082116:desferrioxamine B-succinyl-phenylalanine(1)-octreotide; D003676:Deferoxamine; D015282:Octreotide